ABG-WTT Global Life Science Capital Partners GP Ltd

In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), ABG-WTT Global Life Science Capital Partners GP Ltd reported 2 stock positions worth $15.0 million. Its top holding was Ceribell (CBLL) at 64.4% of the portfolio, followed by Rapid Micro Biosystems Class A (RPID, 35.6%). Compared with Q3 2025, it reduced 1. The biggest sale was Ceribell (CBLL, shares −59%).

Most Recent 13F
Q2 2026
Location
CENTRAL, HONG KONG, K3
CIK
0001832108
Portfolio Value
$15.0M (Q4 2025)
SEC Filing
0001193125-26-055042 ↗ filed Feb 17, 2026

Holdings Value

0$10.0M$20.0M$30.0M$40.0M$50.0M Q1 2024: $41.5M Q1 2024 Q2 2024: $30.0M Q2 2024 Q3 2024: $20.1M Q3 2024 Q4 2024: $43.7M Q4 2024 Q1 2025: $38.3M Q1 2025 Q2 2025: $26.8M Q2 2025 Q3 2025: $18.7M Q3 2025 Q4 2025: $15.0M $15.0M Q4 2025 Q1 2026: $12.3M Q1 2026 Q2 2026: $8.6M Q2 2026

Holdings 2 stocks · $15.0M
CBLL Ceribell Inc. 64.38% 441,820 $9.7M Reduce -59.4%
RPID Rapid Micro Biosystems Inc. Class A 35.62% 1,848,296 $5.4M No change

Portfolio Sells Q3 2025 → Q4 2025
CBLL Ceribell Inc. Reduce -59.4% 64.38% −2.56

Portfolio Buys Q3 2025 → Q4 2025
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 2$8.6MCBLL, RPID
Q1 2026 2$12.3MCBLL, RPID
Q4 2025 2$15.0MCBLL, RPID
Q3 2025 2$18.7MCBLL, RPID
Q2 2025 2$26.8MCBLL, RPID
Q1 2025 4$38.3MCBLL, CGON, RPID, LUNG
Q4 2024 4$43.7MCBLL, CGON, RPID, LUNG
Q3 2024 3$20.1MCGON, RPID, LUNG
Q2 2024 3$30.0MCGON, RPID, LUNG
Q1 2024 3$41.5MCGON, RPID, LUNG